CoChat

Characterization of a New Enterococcal Gene, satG , Encoding a Putative Acetyltransferase Conferring Resistance to Streptogramin A Compounds

Open access
Werner, G., Witte, W. · 1999 · Antimicrobial Agents and Chemotherapy
Cited by 70

The DOI matches its Crossref record.

Abstract

Streptogramin antibiotics are mixtures of two chemically unrelated A and B compounds that act synergistically in vivo against gram-positive pathogens, such as staphylococci, streptococci, and enterococci (8, 11). Resistance against B compounds is very widespread among enterococci and is mediated via the ermBgene cluster (e.g., on Tn917) that confers macrolide-lincosamide-streptogramin B resistance (7). The synergistic mixture of streptogramins A and B overcomes resistance to B compounds but is inactive in resistance to A compounds. The only known resistance mechanism against streptogramin A compounds in enterococci is mediated by the streptogramin acetyltransferase SatA (9). Enterococcus faecium isolates withsatA-mediated resistance have been found in samples of human and animal origins, indicating a possible spread of resistance genes or resistant bacteria among different ecosystems (10).Fig. 1.A 904-bp sequence located on the 5.5-kbp cloned fragment in pUC18 (GenBank accession no. AF139725). The ORF begins at nucleotide 63 with an ATG start codon preceding a putative ribosomal binding site (RBS) (double-underlined) at positions 50 to 57. The predicted gene sequence encodes a protein of 214 aa which shows significant homology with other streptogramin acetyltransferases (aa motifs I, II, III; see also Fig. 2). The locations of the primers satG1 and satG2, specific only for the satG sequence, are underlined (plus strand).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.43.7.1813

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Werner, G., & Witte, W.
Venue
Antimicrobial Agents and Chemotherapy
Published
1999-07
Volume
43
Issue
7
Pages
1813-1814
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W1540026877
Cited by
70
References
0
FWCI
4.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.